Prof. (Tishreen University) Dr. med. Samer Akel
Physician in Charge of Hematology-Oncology
Board-certified specialist in internal medicine with a focus on hematology and oncology
Prof. Dr. med. Samer Akel was appointed associate professor of internal medicine, hematology, and oncology at Tishreen University in Syria in 2021.
In 2009, he earned his doctorate from Friedrich-Alexander University of Erlangen and is recognized in Germany as a board-certified specialist in internal medicine with a focus on hematology and oncology. In addition, he has earned a special qualification in palliative care. In 2001, he was awarded a postgraduate diploma with honors from Tishreen University. Prof. Dr. med. Akel has been repeatedly examined and certified by the ESMO (European Society for Medical Oncology).
He is a member of several professional associations:
- German Society for Hematology and Oncology (DGHO)
- European Society for Medical Oncology (ESMO)
- Emirates Oncology Society (EOS) and Emirates Hematology Society (EHS)
- Syrian Medical Association (SMA)
"The future belongs to an approach to oncology that specifically combines tumor biology, proven treatment modalities, and the immune response."
Prof. Samer Akel, M.D.
Collection: Scientific Papers and International Publications by Prof. Dr. med. Samer Akel
"CD38 Expression as an Important Prognostic Factor in Chronic Lymphocytic
"
Tishreen University Journal for Research and Scientific Studies
Health Sciences Series, Vol. (41), No. (6), 2019, pp. 161–174
Firas Hussain, Samer Akel, Sujek Artin
The Relationship between Body Mass Index and Histomolecular Classification of Breast Cancer
Tishreen University Journal for Research and Scientific Studies
Health Sciences Series Vol. (42) No. (5) 2020. pp. 367–375
Nader Abedallaa, Samer Akel, Zaina Watfa
Relationship between Vitamin D and Glycemic Control in Patients with Type II Diabetes Mellitus in Latakia
World Journal of Advanced Healthcare Research.
ISSN: 2457-0400 Volume: 2. Issue: 5. Pages 220–225 Year: 2018
Abdulrahman Ahmad Zuraik, Samer Akel, Ayman Awwama
Clinical and Histological Characteristics of Hodgkin’s Lymphoma in the Syrian Coastal Region
Tishreen University Journal for Research and Scientific Studies
Health Sciences Series, Vol. (43), No. (4), 2021, pp. 107–116
Samer Akel
Assessment of Two Main Therapeutic Regimens for Chronic Lymphocytic Leukemia at a Major Referral Center in Syria.
Acta Haematologica Polonica 2022.
Issue 4, Volume 53, pp. 277–284
Lujain Hamdan, Firas Hussein, Samer Akel
Comparison of Clinical Outcomes of Adjuvant Chemotherapy Between the Right and Left Colon.
Journal of Medical & Pharmaceutical Sciences
Volume (6), Issue (5): September 30, 2022. pp. 14–30
Marmar Samea Kanaan, Nader Abedallaa, Samer Akel
Prevalence of MTHFR Gene (C677T and A1298C) Polymorphisms in the Syrian Coastal Area
Research J. Pharm. and Tech 2023; 16(9). pp. 4365–4369.
Ariana Younes, Mazen Khaddour, Mazen Salloum, Suzan Samra, Samer Akel
Further information on this topic:
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de